Here's the live share price of Beta Drugs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Beta Drugs has gained 85.39% CAGR. Over the past year, the corresponding return has been 5.27%.
Beta Drugs’s current P/E of 43.33x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Beta Drugs | -1.61 | -5.49 | 1.80 | 8.88 | 5.27 | 34.26 | 85.39 |
Sun Pharmaceutical Industries | 1.68 | -0.77 | -1.82 | -4.93 | -13.18 | 22.80 | 25.91 |
Divi's Laboratories | 0.33 | -1.83 | -7.44 | 6.71 | 10.99 | 18.69 | 13.51 |
Cipla | -0.27 | -0.36 | 3.73 | 4.49 | -6.71 | 14.60 | 15.72 |
Torrent Pharmaceuticals | -1.21 | -2.83 | 9.00 | 15.72 | 2.75 | 33.83 | 20.09 |
Dr. Reddy's Laboratories | 0.55 | 3.86 | -0.56 | 13.97 | -1.13 | 16.95 | 6.32 |
Mankind Pharma | -1.47 | 3.96 | 9.22 | 18.39 | 4.67 | 21.80 | 12.56 |
Zydus Lifesciences | -0.56 | 4.79 | 7.95 | 15.81 | -6.94 | 42.16 | 21.30 |
Lupin | 2.60 | 3.20 | 4.49 | 1.98 | -10.54 | 46.86 | 14.39 |
Abbott India | -0.91 | -4.97 | -2.61 | 2.63 | 7.31 | 21.24 | 13.50 |
Alkem Laboratories | 2.86 | 2.37 | 13.70 | 13.58 | -11.97 | 18.98 | 14.01 |
Aurobindo Pharma | 4.32 | 0.59 | -1.26 | -1.44 | -29.42 | 28.24 | 6.21 |
Glenmark Pharmaceuticals | -4.15 | 3.47 | 23.54 | 42.87 | 19.23 | 76.68 | 32.90 |
Anthem Biosciences | 6.05 | 7.97 | 18.37 | 18.37 | 18.37 | 5.78 | 3.43 |
Laurus Labs | -0.27 | 3.27 | 35.33 | 53.77 | 78.31 | 20.77 | 26.10 |
Biocon | -2.70 | -2.73 | 0.48 | 6.33 | -5.72 | 6.91 | -4.33 |
GlaxoSmithKline Pharmaceuticals | -3.37 | -1.86 | -15.73 | 1.80 | -2.03 | 24.86 | 9.23 |
Cohance Lifesciences | -2.37 | 7.69 | -2.89 | -14.87 | -16.53 | 28.10 | 20.30 |
Ipca Laboratories | -0.14 | -5.25 | -3.52 | -0.49 | -10.00 | 15.16 | 4.04 |
Gland Pharma | 4.44 | 0.70 | 13.50 | 27.63 | 7.66 | -4.02 | 1.78 |
Over the last one year, Beta Drugs has gained 5.27% compared to peers like Sun Pharmaceutical Industries (-13.18%), Divi's Laboratories (10.99%), Cipla (-6.71%). From a 5 year perspective, Beta Drugs has outperformed peers relative to Sun Pharmaceutical Industries (25.91%) and Divi's Laboratories (13.51%).
Day | SMA | EMA |
---|---|---|
5 | 1,845.53 | 1,835.31 |
10 | 1,869.37 | 1,851.95 |
20 | 1,890.49 | 1,856.94 |
50 | 1,804.02 | 1,831.53 |
100 | 1,803.09 | 1,811.02 |
200 | 1,820.1 | 1,761.72 |
In the latest quarter, Beta Drugs remained same as its previous close in promoter holding, while DII stake increased to 0.25%, FII holding unchanged at 0.90%, and public shareholding moved down to 32.10% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
There's no recent Announcement information to show for the company. You may visit the Beta Drugs fact sheet for more information
Beta Drugs Ltd. is a Public Limited Listed company incorporated on 21/09/2015 and has its registered office in the State of Himachal Pradesh, India. Company's Corporate Identification Number(CIN) is L24230HP2005PLC028969 and registration number is 028969. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 220.20 Cr. and Equity Capital is Rs. 10.09 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Beta Drugs is ₹1,820.75 as on Sep 17, 2025.
The Beta Drugs is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the NSE.
The market cap of Beta Drugs is ₹1,837.97 Cr as on Sep 17, 2025.
Today’s highest and lowest price of Beta Drugs are ₹1,854.90 and ₹1,819.20.
The 52-week high/low is the highest and lowest price at which Beta Drugs stock has traded in the past 52-week or nearly a year. The 52-week high of Beta Drugs is ₹2,214.35 and 52-week low of Beta Drugs is ₹1,428.95 as on Sep 17, 2025.
The Beta Drugs has shown returns of 0.13% over the past day, -5.49% for the past month, 1.8% over 3 months, 5.27% over 1 year, 34.26% across 3 years, and 85.39% over 5 years.
P/E ratio of and PB ratio of Beta Drugs are 43.33 and 10.16 on Sep 17, 2025. While the company gives a dividend yield of 0.00 per annum.